Ten-day vonoprazan–amoxicillin dual therapy versus 14-day esomeprazole–amoxicillin dual therapy for first-line <i>Helicobacter pylori</i> eradication: a prospective multicenter randomized controlled trial
- DOI
- 10.1177/17562848241309870
- Published
- 2024-01
- Container
- Therapeutic Advances in Gastroenterology
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/17562848241309870,
title = {Ten-day vonoprazan–amoxicillin dual therapy versus 14-day esomeprazole–amoxicillin dual therapy for first-line
<i>Helicobacter pylori</i>
eradication: a prospective multicenter randomized controlled trial},
author = {Ben-Gang Zhou and Ming-Wen Guo and Li-Juan Zhang and Zhi-Dong Liu and Chun-Hua Liu and Xue-Feng Li and Shun-Song Li and Peng Xiao and Bing Bao and Yao-Wei Ai and Yan-Bing Ding},
year = {2024},
journal = {Therapeutic Advances in Gastroenterology},
doi = {10.1177/17562848241309870},
url = {https://doi.org/10.1177/17562848241309870}
}RIS
TY - JOUR
TI - Ten-day vonoprazan–amoxicillin dual therapy versus 14-day esomeprazole–amoxicillin dual therapy for first-line
<i>Helicobacter pylori</i>
eradication: a prospective multicenter randomized controlled trial
AU - Ben-Gang Zhou
AU - Ming-Wen Guo
AU - Li-Juan Zhang
AU - Zhi-Dong Liu
AU - Chun-Hua Liu
AU - Xue-Feng Li
AU - Shun-Song Li
AU - Peng Xiao
AU - Bing Bao
AU - Yao-Wei Ai
AU - Yan-Bing Ding
PY - 2024
JO - Therapeutic Advances in Gastroenterology
DO - 10.1177/17562848241309870
UR - https://doi.org/10.1177/17562848241309870
ER - APA
Zhou, B., Guo, M., Zhang, L., Liu, Z., Liu, C., Li, X., Li, S., Xiao, P., Bao, B., Ai, Y., & Ding, Y. (2024). Ten-day vonoprazan–amoxicillin dual therapy versus 14-day esomeprazole–amoxicillin dual therapy for first-line <i>Helicobacter pylori</i> eradication: a prospective multicenter randomized controlled trial. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/17562848241309870
Source records
- crossref · retrieved 2026-09-25T21:59:30.057Z